An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

The aim of the study was to evaluate the response rate and safety of weekly paclitaxel (Taxol®) combination chemotherapy with UFT (tegafur, an oral 5-fluorouracil prodrug, and uracil at a 1 : 4 molar ratio) and leucovorin (LV) in patients with advanced gastric cancer. Patients with histologically co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Y, Li, C P, Chao, T Y, Su, W C, Hsieh, R K, Wu, M F, Yeh, K H, Kao, W Y, Chen, L T, Cheng, A L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360611/
https://www.ncbi.nlm.nih.gov/pubmed/16804524
http://dx.doi.org/10.1038/sj.bjc.6603225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360611/
https://www.ncbi.nlm.nih.gov/pubmed/16804524
http://dx.doi.org/10.1038/sj.bjc.6603225

Ejemplares similares